Cardiac pharmacology Flashcards
What are pharmacological properties of clopidogrel
Class of drug: Platelet ADP (adenosine diphosphate) receptor antagonist
Clopidogrel irreversibly modifies the platelet ADP receptor thereby directly inhibiting the binding of ADP and subsequent ADP-mediated activation of the glycoprotein IIb/IIIa complex.
What are the pharmacological properties of heparin
- inactivates factor Xa
- inhibits conversion of prothrombin to thrombin
- prevents fibrin formation from fibrinogen
More details of heparin physiology
Acts near the end of the coagulation cascade
The first target is thrombin (Factor II) –by activation Anti-Thrombin III (AT III) to a form > 1000times more potent
also targets Xa, XIIIa, XIa
Full dose does not completely suppress thrombin
Heparin comes pork intestine or beef lung* different*
What are differences between UF heparin and low moelecular weight heparin
a) longer half-life, about 12 hours compared to 90 min
b) does not require monitoring
c) greater anti-factor Xa activity
d) lower incidence of thrombocytopenia and osteoporosis
What is advantage LWMH
↓ heparin resistance ↓ inhibition of platelet function ↓ incidence of HIT 1 vs 5 % ↓ risk of bleeding ↑ bioavailability ↑ half life No need for monitoring
What are pharmacological properties of warfarin
Coumadin derivative that interferes with vitamin K metabolism.
Vit K is a co-factor in the hepatic production of Factors II, VII, IX, and X.
What are pharmacological properties of glycoprotein IIb/IIIa blockers
Inhibit platelet aggregation by binding to the glycoprotein IIb/IIIa receptors on platelets thereby preventing these receptors from linking to other platelets by fibrinogen cross-bridges.
examples
1) Abciximab
2) tirogibran
3) eptifibatide
Pharmacological properties of fibrinolytics
convert plasminogen to plasmin which in turn degrades fibrin-containing thrombi.
Two categories
a) non-specific thrombolytic agents
b) fibrin-specific
Pharmacological properies of Transexamic acid
lysine analogue anti-fibrinolytic agent
Binds to plasminogen, therby inhibiting fibrinolysis
possible renal function and graft patency issues
Pharmacological properties of statins
competitively inhibit hepatic HMG-CoA reductase, which is involved in last step of cholesterol synthesis
What are pharmacological properties of beta blockers
Bind to beta adrenoreceptors to produce negative inotropic and chrontropic effects, thereby reducing myocardial oxygen demand.
cardiomyocyte membrane stabilizing effect, thereby acting as an anti-arrhythmic agent
What are pharmacological properties of calcium channel blockers
inhibit calcium influx during phase 2 of cardiac action potential (plateau phase) thereby reducing cardiac contractility and the propagation of cardiac electrical impulses
also relax vascular smooth muscle, dilating coronary and peripheral arteries
What are pharmacoloical properties of ACE inhibitors
Prevent conversion of inactive angiotensin I to active angiotensin II, thereby reducing the release of aldosterone by the adrenal cortex.
ARBs have similar mechanism as ACE but do not break down bradykinin which is thought to be responsible for the cough
What are pharmacological properties of nitrates
smooth muscle relaxants that
1) coronary vasodilation and reduced coronary spasm
2) peripherally vasodilate
3) reduce preload and afterload, thereby reducing myocardial oxygen demand
What are pharmacological mechanism of nitroprusside
relaxes arterial smooth thereby reducing systemic and pulmonary afterload
use for aortic dissection
What are pharmacological properties of dopamine
Dopaminergic and adrenergic receptor agonist ug/kg/min
Good for low cardiac output and post MI
What are pharmacological properties of dobutamine
synthetic inodilator that activates B1 adrenergic receptors and has moderate B2 (vasodilaton)
what are pharmacological properties of adrenaline
A potent alpha 1 agonist producing increased myocardiac contractility and increased heart rate. At low doses it does B2 vasodilation.
will cause metabolic acidosis
What are pharmacological properties of noradrenaline
Potent alpha 1 agonist producing systemic vasoconstriction and beta 1 increasing myocardial contracility
How does Milrinone work
Inhibition of phosphodiesterase enzyme, which normally converts to cAMP to inactive 5 -AMP
What are pharmacoligcal properties of milirinone
Acts as an inodilator by reducing systemic and pulmonary vascular resistance as well as having moderate positive inotropic effects
phosphodiesterase- 3–inhibitor
What are pharmacological properties of digoxin
Inhibits the action of the sarcolemmal membrane Na-K-ATPase thereby inhibiting the sodium pump.This results in a greater influx of sodium and development of bound intracellular calcium producing weak inotropic effect.
prolongs the atroventricular node refractory period and conduction, as well as stimulating vagal function thereby slowing down the ventricular rate
What are the pharmacological properties of amiodarone
increases the action potential duration throughout the cardiac conduction system, thereby reducing the excitability of both atrial and ventricular myocytes
What are the pharmacological properties of loop diuretics
loop diuretics inhibit water and electrolyte reabsorption from the ascending limb of henle
List 2 source of Nitric oxide and the effects of NO on endothelium
Source of NO
Active byproduct of nitrates and NA nitroprusside
Inhaled NO
The effects of NO on endothelium reduced cytosolic CA+ reduce platelet aggregation increase cGMP increase guanylate cyclase
What is the mechanism of nitrate intolerance
Reduced bioconversion to NO Desensitization of guanyl cyclase increased vasopressin and catecholamines Renin-angiotensive system activation Increased production of endothelin-1 increased superoxide anion production
What are usual doses of inotropes that maybe required to come off CPB for difficult wean are
Milrinone: 50u/KG loading dose, then 0.5u/kg/min infusion
Epinephrine -0.01-to0.1u/kg/min
NE is 0.01 to 0.03 u/kg/min
Dopamine 5 to 15 u/kg/min
Dobutmaine 5 to 15 u/kg/min
Phenylephrine 40 to 70 u boluses every few minutes
List 5 effects on the vascular endothelium from Nitric Oxide
Vasodilation
inhibits vascular smooth muscle growth
inhibits platelet aggregation and adhesion
inhibits neutrophil adhesion
List indications for nitric oxide
pulmonary hypertension post-heart transplant
pulmonary hypertension post repair of congential heart lesion—VSD
pulmonary hypertension following mitral valve repair
treat acute right heart failure/dysfunction
massive acute PE
ARDS
following lung transplantation